XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
LEASES
3 Months Ended
Mar. 31, 2022
LEASES  
LEASES

NOTE 13 – LEASES

 

The Company has various lease agreements with terms up to 10 years, comprising leases of office space, cars leases for the distribution of pharmaceutical products, equipment hires, etc. Some leases include options to purchase, terminate or extend for one or more years. These options are included in the lease term when it is reasonably certain that the option will be exercised.

 

The assets and liabilities from operating and finance leases are recognized at the commencement date based on the present value of remaining lease payments over the lease term using the Company’s secured incremental borrowing rates or implicit rates, when readily determinable. Short-term leases, which have an initial term of 12 months or less, are not recorded on the balance sheet.

 

The Company’s operating leases do not provide an implicit rate that can readily be determined. Therefore, we use a discount rate based on our incremental borrowing rate, which is determined using the interest rate of our long-term debt on the date of inception.

 

Operating Leases

 

The Company’s weighted-average remaining lease term relating to its operating leases is 6.47 years, with a weighted-average discount rate of 6.74%.

 

The Company incurred lease expense for its operating leases of $54,124 and $65,577 which was included in “General and administrative expenses,” for the three months ended March 31, 2022 and 2021, respectively.

 

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of March 31, 2022.

 

Maturity of Lease Liability

 

 

 

Remainder of 2022

 

$154,095

 

2023

 

 

177,914

 

2024

 

 

108,485

 

2025

 

 

108,485

 

Thereafter

 

 

408,810

 

Total undiscounted operating lease payments

 

$957,789

 

Less: Imputed interest

 

 

(182,247)

Present value of operating lease liabilities

 

 

775,542

 

Finance leases

 

The Company’s weighted-average remaining lease term relating to its finance leases is 2.93 years, with a weighted-average discount rate of 6.74%.

 

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s finance leases as of March 31, 2022.

 

Maturity of Lease Liability

 

 

 

Remainder of 2022

 

$62,941

 

2023

 

 

73,387

 

2024

 

 

56,654

 

2025

 

 

26,870

 

Thereafter

 

 

3,694

 

Total undiscounted finance lease payments

 

$223,546

 

Less: Imputed interest

 

 

(20,669)

Present value of finance lease liabilities

 

$202,877

 

 

The Company incurred interest expense on its finance leases of $3,507 which was included in “Interest expense,” for the three months ended March 31, 2022. The Company incurred amortization expense on its finance leases of $19,580 which was included in “Depreciation and amortization expense,” for the three months ended March 31, 2022. The total cash used for the Company’s finance leases for the three months ended March 31, 2022 amounted to $22,358.